Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · Real-Time Price · USD
5.44
-0.21 (-3.72%)
Jun 26, 2025, 4:00 PM - Market closed
Astria Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$32.43
Upside
+496.14%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +194.12% | Jun 13, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $47 | Buy | Reiterates | $47 | +763.97% | May 14, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $47 | Buy | Initiates | $47 | +763.97% | Apr 29, 2025 |
| Wedbush | Wedbush | Buy Maintains $27 → $28 | Buy | Maintains | $27 → $28 | +414.71% | Mar 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +194.12% | Mar 11, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $26 | Buy | Reiterates | $26 | +377.94% | Mar 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +194.12% | Feb 27, 2025 |
| JMP Securities | JMP Securities | Buy Initiates $26 | Buy | Initiates | $26 | +377.94% | Jan 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +194.12% | Jan 23, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +194.12% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Dec 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +194.12% | Dec 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +194.12% | Nov 14, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $26 → $28 | Buy | Maintains | $26 → $28 | +414.71% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +194.12% | Sep 27, 2024 |
| Wedbush | Wedbush | Buy Reiterates $22 | Buy | Reiterates | $22 | +304.41% | Aug 13, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.